Viewing Study NCT05125302

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT05125302
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2021-11-08
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Migraine View
None Ubrogepant View
None Ubrelvy View
None PERISCOPE View